Scott P. Henry

5.5k citations

105 papers · 3.8k indexed · h-index 35

Molecular Biology top 2%
Immunology top 5%
Genetics top 2%
Genetics top 10%
Cancer Research top 10%

Co-authors: Richard S. Geary Arthur A. Levin Douglas J. Kornbrust Rosie Z. Yu Carol S. Auletta David Monteith C. Frank Bennett Sebastien A. Burel
Topics: DNA and Nucleic Acid Chemistry (30 papers)RNA Interference and Gene Delivery (26 papers)Advanced biosensing and bioanalysis techniques (23 papers)
Cited by: Genetics Molecular Biology Immunology
Journals: Nucleic Acids Research Circulation Journal of Clinical Oncology
Partner nations: United States Sweden South Korea

In The Last Decade

Scott P. Henry

102 papers receiving 3.6k citations

Peers

Countries citing papers authored by Scott P. Henry

Since Specialization

Citations

This map shows the geographic impact of Scott P. Henry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott P. Henry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott P. Henry more than expected).

Fields of papers citing papers by Scott P. Henry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott P. Henry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott P. Henry. The network helps show where Scott P. Henry may publish in the future.

Co-authorship network of co-authors of Scott P. Henry

This figure shows the co-authorship network connecting the top 25 collaborators of Scott P. Henry. A scholar is included among the top collaborators of Scott P. Henry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott P. Henry. Scott P. Henry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Inhibiting the alternative pathway of complement by reducing systemic complement factor B: Randomized, double-blind, placebo-controlled phase 1 studies with Sefaxersen 2025 ·Immunobiology ·Michael L. McCaleb,Steven G. Hughes,Tamar R. Grossman,Ashley Frazer‐Abel,(unknown),(unknown),Scott P. Henry,Brett P. Monia,Eugene Schneider,Richard S. Geary,(unknown)	2
2	Acute neuronal inhibition response caused by phosphorothioate antisense oligonucleotides following local delivery to the central nervous system 2025 ·Nucleic Acids Research ·(unknown),(unknown),Curt Mazur,(unknown),Oleksandr Platoshyn,(unknown),(unknown),(unknown),Sebastien A. Burel,(unknown),Thomas A. Zanardi,(unknown),(unknown),Scott P. Henry,Eric E. Swayze,Berit Powers,Holly Kordasiewicz	0
3	CpG oligonucleotides induce acute murine thrombocytopenia dependent on toll-like receptor 9 and spleen tyrosine kinase pathways 2024 ·Journal of Thrombosis and Haemostasis ·Karl Johansson,(unknown),Johan Rebetz,Geneviève Marcoux,Oonagh Shannon,Joseph E. Italiano,N. Padma,Scott P. Henry,Lijiang Shen,John W. Semple	1
4	A Combined Fertility and Developmental Toxicity Study with an Antisense Oligonucleotide Targeting Murine Apolipoprotein C-III mRNA in Mice 2024 ·Nucleic Acid Therapeutics ·Ji‐Seong Jeong,(unknown),Tae‐Won Kim,Scott P. Henry,(unknown),Sang Yun Kim,Woojin Kim,Sun Young Lee,(unknown),(unknown),Wook‐Joon Yu,(unknown)	0
5	Complement C3d/C4d Deposition on Platelets Correlates with 2′-O-Methoxyethyl Antisense Oligonucleotide-Induced Thrombocytopenia in Monkeys 2023 ·Nucleic Acid Therapeutics ·Lijiang Shen,Andrea Li Ann Wong,Satoru Oneda,Brian R. Curtis,(unknown),(unknown),Jeffery A. Engelhardt,Scott P. Henry,(unknown)	3
6	Antisense Oligonucleotide-Related Macrovesicular Vacuolation of Hippocampal Neurons in Nonhuman Primates 2022 ·Toxicologic Pathology ·Martin Lamb,(unknown),Branka Grubor,William A. Meier,(unknown),Scott P. Henry,James Fikes	4
7	Early-Stage Identification and Avoidance of Antisense Oligonucleotides Causing Species-Specific Inflammatory Responses in Human Volunteer Peripheral Blood Mononuclear Cells 2022 ·Nucleic Acid Therapeutics ·Sebastien A. Burel,Todd Machemer,Brenda F. Baker,T. Jesse Kwoh,(unknown),Husam S. Younis,Scott P. Henry	14
8	Inflammatory Non-CpG Antisense Oligonucleotides Are Signaling Through TLR9 in Human Burkitt Lymphoma B Bjab Cells 2022 ·Nucleic Acid Therapeutics ·(unknown),(unknown),Todd Machemer,(unknown),Sagar Damle,Scott P. Henry,Sebastien A. Burel	12
9	Assessment of the Immunogenicity Potential for Oligonucleotide-Based Drugs 2022 ·Nucleic Acid Therapeutics ·Scott P. Henry,Cecilia Arfvidsson,(unknown),(unknown),David Crowe,Shalini Gupta,(unknown),(unknown),Daniel T. Mytych,(unknown),Hobart Rogers,(unknown),(unknown),Daniela Verthelyi,(unknown),(unknown),Yuanxin Xu,Rosie Z. Yu,(unknown)	8
10	Interspecies Scaling of Human Clearance and Plasma Trough Exposure for Antisense Oligonucleotides: A Retrospective Analysis of GalNAc3-Conjugated and Unconjugated-Antisense Oligonucleotides 2021 ·Nucleic Acid Therapeutics ·(unknown),(unknown),Rosie Z. Yu,Richard S. Geary,Scott P. Henry,Yanfeng Wang	11
11	Underlying Immune Disorder May Predispose Some Transthyretin Amyloidosis Subjects to Inotersen-Mediated Thrombocytopenia 2020 ·Nucleic Acid Therapeutics ·(unknown),Brian R. Curtis,Lijiang Shen,Eugene Schneider,Joseph A. Tami,(unknown),Sebastien A. Burel,Bruce L. Tai,Todd Machemer,T. Jesse Kwoh,Shuting Xia,Sanford J. Shattil,Joseph L. Witztum,Jeffery A. Engelhardt,Scott P. Henry,Brett P. Monia,Steven G. Hughes	26
12	Impurity Qualification Toxicology Study for a 2′-O-Methoxyethyl-Modified Antisense Inhibitor in Mice 2019 ·Nucleic Acid Therapeutics ·Tae‐Won Kim,(unknown),Daniel C. Capaldi,A. McPherson,(unknown),(unknown),(unknown),(unknown),(unknown),Scott P. Henry	1
13	Chronic Toxicity Assessment of 2′- O -Methoxyethyl Antisense Oligonucleotides in Mice 2018 ·Nucleic Acid Therapeutics ·Thomas A. Zanardi,Tae‐Won Kim,Lijiang Shen,(unknown),(unknown),Shin‐Young Park,(unknown),Scott P. Henry	16
14	Systemic Pharmacodynamic Efficacy of a Complement Factor B Antisense Oligonucleotide in Preclinical and Phase 1 Clinical Studies 2017 ·Investigative Ophthalmology & Visual Science ·Michael L. McCaleb,Tamar R. Grossman,Peter Adamson,Scott P. Henry,Richard S. Geary,Steve Hughes,Brett P. Monia	5
15	Lack of QT Prolongation for 2′- O -Methoxyethyl-Modified Antisense Oligonucleotides Based on Retrospective Exposure/Response Analysis of Ten Phase 1 Dose-Escalation Placebo-Controlled Studies in Healthy Subjects 2017 ·Nucleic Acid Therapeutics ·Rosie Z. Yu,Rudy Gunawan,Richard S. Geary,Steven G. Hughes,Scott P. Henry,Yanfeng Wang	8
16	Assessment of the Drug Interaction Potential of Unconjugated and GalNAc3-Conjugated 2′-MOE-ASOs 2017 ·Molecular Therapy — Nucleic Acids ·Colby S. Shemesh,Rosie Z. Yu,Mark S. Warren,Michael Liu,(unknown),Brandon Nichols,Noah Post,Song Lin,Daniel A. Norris,Eunju Hurh,(unknown),Tanya Watanabe,Scott P. Henry,Yanfeng Wang	27
17	Effects of Repeated Complement Activation Associated with Chronic Treatment of Cynomolgus Monkeys with 2′- O -Methoxyethyl Modified Antisense Oligonucleotide 2016 ·Nucleic Acid Therapeutics ·Lijiang Shen,(unknown),Gene Hung,(unknown),Rie Kikkawa,John Matson,(unknown),Todd Machemer,Patricia C. Giclas,Scott P. Henry	18
18	Mechanistic Understanding for the Greater Sensitivity of Monkeys to Antisense Oligonucleotide–Mediated Complement Activation Compared with Humans 2014 ·Journal of Pharmacology and Experimental Therapeutics ·Lijiang Shen,Ashley Frazer‐Abel,Paul R. Reynolds,Patricia C. Giclas,Alfred E. Chappell,Michael K. Pangburn,Husam S. Younis,Scott P. Henry	34
19	Comparison of the toxicity profiles of ISIS 1082 and ISIS 2105, phosphorothioate oligonucleotides, following subacute intradermal administration in Sprague-Dawley rats 1997 ·Toxicology ·Scott P. Henry,Lisa R. Grillone,(unknown),Richard H. Bruner,Douglas J. Kornbrust	35
20	Purification and Characterization of Bovine Heart Glycogen Synthase Kinase-3 1994 ·Preparative Biochemistry ·Scott P. Henry,S. Derek Killilea	1

About Scott P. Henry

Scott P. Henry is a scholar working on Immunology, Genetics and Hematology, having authored 105 papers that have together received 3.8k indexed citations. Recurring topics across this work include DNA and Nucleic Acid Chemistry (30 papers), RNA Interference and Gene Delivery (26 papers) and Advanced biosensing and bioanalysis techniques (23 papers). The work is most often cited by research in Genetics (423 citations), Molecular Biology (2.7k citations) and Immunology (636 citations). Scott P. Henry has collaborated with scholars based in United States, Sweden and South Korea. Frequent co-authors include Richard S. Geary, Arthur A. Levin, Douglas J. Kornbrust, Rosie Z. Yu, Carol S. Auletta, David Monteith, C. Frank Bennett, Sebastien A. Burel, Lisa R. Grillone and Patricia C. Giclas. Their work appears in journals such as Nucleic Acids Research, Circulation and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact